Status:
COMPLETED
A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy
Lead Sponsor:
UCB Pharma
Conditions:
Diabetic Neuropathy
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
This phase 2b trial is being conducted at approximately 60 sites in the US to investigate whether lacosamide (SPM 927) at different doses reduces pain in subjects with diabetic neuropathy. Approximate...
Eligibility Criteria
Inclusion
- Painful distal diabetic neuropathy
Exclusion
- Must have an average pain intensity of ≥ 4 on an 11-point Likert scale
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2005
Estimated Enrollment :
496 Patients enrolled
Trial Details
Trial ID
NCT00235469
Start Date
April 1 2004
End Date
June 1 2005
Last Update
September 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schwarz
RTP, North Carolina, United States